相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women
Leila Dorling et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Functional interrogation of DNA damage response variants with base editing screens
Raquel Cuella-Martin et al.
CELL (2021)
CHEK2 Germline Variants in Cancer Predisposition: Stalemate Rather than Checkmate
Lenka Stolarova et al.
CELLS (2020)
Functional characterization of CHEK2 variants in a Saccharomyces cerevisiae system
Angeliki Delimitsou et al.
HUMAN MUTATION (2019)
Functional analysis of genetic variants in the high-risk breast cancer susceptibility gene PALB2
Rick A. C. M. Boonen et al.
NATURE COMMUNICATIONS (2019)
Predicting Splicing from Primary Sequence with Deep Learning
Kishore Jaganathan et al.
CELL (2019)
Frequent Homologous Recombination Deficiency in High-grade Endometrial Carcinomas
Marthe M. de Jonge et al.
CLINICAL CANCER RESEARCH (2019)
Recommendations for application of the functional evidence PS3/BS3 criterion using the ACMG/AMP sequence variant interpretation framework
Sarah E. Brnich et al.
GENOME MEDICINE (2019)
Multiplex assessment of protein variant abundance by massively parallel sequencing
Kenneth A. Matreyek et al.
NATURE GENETICS (2018)
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer
Fergus J. Couch et al.
JAMA ONCOLOGY (2017)
The complexity of TRIM28 contribution to cancer
Patrycja Czerwinska et al.
JOURNAL OF BIOMEDICAL SCIENCE (2017)
Pathogenic and likely pathogenic variant prevalence among the first 10,000 patients referred for next-generation cancer panel testing
Lisa R. Susswein et al.
GENETICS IN MEDICINE (2016)
Analysis of protein-coding genetic variation in 60,706 humans
Monkol Lek et al.
NATURE (2016)
Damage-induced BRCA1 phosphorylation by Chk2 contributes to the timing of end resection
Balaji Parameswaran et al.
CELL CYCLE (2015)
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Sue Richards et al.
GENETICS IN MEDICINE (2015)
A novel recurrent CHEK2 Y390C mutation identified in high-risk Chinese breast cancer patients impairs its activity and is associated with increased breast cancer risk
N. Wang et al.
ONCOGENE (2015)
Double strand break (DSB) repair in heterochromatin and heterochromatin proteins in DSB repair
Charlene Lemaitre et al.
DNA REPAIR (2014)
ClinVar: public archive of relationships among sequence variation and human phenotype
Melissa J. Landrum et al.
NUCLEIC ACIDS RESEARCH (2014)
Genome engineering using the CRISPR-Cas9 system
F. Ann Ran et al.
NATURE PROTOCOLS (2013)
A High-Throughput Functional Complementation Assay for Classification of BRCA1 Missense Variants
Peter Bouwman et al.
CANCER DISCOVERY (2013)
Response to DNA damage of CHEK2 missense mutations in familial breast cancer
Wendy Roeb et al.
HUMAN MOLECULAR GENETICS (2012)
Roles of Kruppel-associated Box (KRAB)-associated Co-repressor KAP1 Ser-473 Phosphorylation in DNA Damage Response
Chen Hu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Kruppel-associated Box (KRAB)-associated Co-repressor (KAP-1) Ser-473 Phosphorylation Regulates Heterochromatin Protein 1β (HP1-β) Mobilization and DNA Repair in Heterochromatin
Emma Bolderson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Heterochromatin and the DNA damage response: the need to relax
Kendra L. Cann et al.
BIOCHEMISTRY AND CELL BIOLOGY (2011)
Rare, evolutionarily unlikely missense substitutions in CHEK2 contribute to breast cancer susceptibility: results from a breast cancer family registry case-control mutation-screening study
Florence Le Calvez-Kelm et al.
BREAST CANCER RESEARCH (2011)
An Improved Flp Deleter Mouse in C57Bl/6 Based on Flpo Recombinase
Andrea Kranz et al.
GENESIS (2010)
Interdependent Phosphorylation within the Kinase Domain T-loop Regulates CHK2 Activity
Xin Guo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Structure and Activation Mechanism of the CHK2 DNA Damage Checkpoint Kinase
Zhenjian Cai et al.
MOLECULAR CELL (2009)
Identification and characterization of novel SNPs in CHEK2 in Ashkenazi!Jewish men with prostate cancer
Marc D. Tischkowatz et al.
CANCER LETTERS (2008)
Chk2 Oligomerization Studied by Phosphopeptide Ligation IMPLICATIONS FOR REGULATION AND PHOSPHODEPENDENT INTERACTIONS
Jiejin Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
CHEK2 Mutations Affecting Kinase Activity Together With Mutations in TP53 Indicate a Functional Pathway Associated with Resistance to Epirubicin in Primary Breast Cancer
Ranjan Chrisanthar et al.
PLOS ONE (2008)
Genetic and functional analysis of CHEK2 (CHK2) variants in multiethnic cohorts
Daphne W. Bell et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage
Shuhei Matsuoka et al.
SCIENCE (2007)
Novel founder CHEK2 mutation is associated with increased prostate cancer risk
C Cybulski et al.
CANCER RESEARCH (2004)
CHEK2 is a multiorgan cancer susceptibility gene
C Cybulski et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2004)
Limited relevance of the CHEK2 gene in hereditary breast cancer
MR Dufault et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair
JR Zhang et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Chk1 and Chk2 kinases in checkpoint control and cancer
J Bartek et al.
CANCER CELL (2003)
Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility
M Schutte et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
Mutations in CHEK2 associated with prostate cancer risk
XY Dong et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2003)
CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours
N Sodha et al.
BRITISH JOURNAL OF CANCER (2002)
Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription
H Takai et al.
EMBO JOURNAL (2002)
Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner
A Hirao et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer
P Vahteristo et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2002)
Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain
JY Ahn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Low-penetrance susceptibility to breast cancer due to CHEK2*1100delC in noncarriers of BRCA1 or BRCA2 mutations
H Meijers-Heijboer et al.
NATURE GENETICS (2002)
Structural and functional versatility of the FHA domain in DNA-damage signaling by the tumor suppressor kinase Chk2
JJ Li et al.
MOLECULAR CELL (2002)
Mutation analysis of the CHK2 gene in breast carcinoma and other cancers
S Ingvarsson et al.
BREAST CANCER RESEARCH (2002)
The hCds1 (Chk2)-FHA domain is essential for a chain of phosphorylation events on hCds1 that is induced by ionizing radiation
CH Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
DNA damage-induced activation of p53 by the checkpoint kinase Chk2
A Hirao et al.
SCIENCE (2000)
分享论文
